Australia markets closed

Microba Life Sciences Limited (MAP.AX)

ASX - ASX Delayed price. Currency in AUD
Add to watchlist
0.1600-0.0100 (-5.88%)
At close: 03:30PM AEST
Currency in AUD

Valuation measures4

Market cap (intra-day) 71.66M
Enterprise value 44.98M
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)8.98
Price/book (mrq)1.46
Enterprise value/revenue 6.88
Enterprise value/EBITDA -2.72

Trading information

Stock price history

Beta (5Y monthly) 2.75
52-week change 3-39.45%
S&P500 52-week change 325.01%
52-week high 30.4247
52-week low 30.1500
50-day moving average 30.1830
200-day moving average 30.2393

Share statistics

Avg vol (3-month) 3179.88k
Avg vol (10-day) 3228.06k
Shares outstanding 5447.85M
Implied shares outstanding 6447.85M
Float 8235M
% held by insiders 142.25%
% held by institutions 126.99%
Shares short 4N/A
Short ratio 4N/A
Short % of float 4N/A
Short % of shares outstanding 4N/A
Shares short (prior month ) 4N/A

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 30 June 2023
Most-recent quarter (mrq)31 Dec 2023


Profit margin -282.64%
Operating margin (ttm)-436.94%

Management effectiveness

Return on assets (ttm)-27.33%
Return on equity (ttm)-39.09%

Income statement

Revenue (ttm)6.54M
Revenue per share (ttm)0.02
Quarterly revenue growth (yoy)52.10%
Gross profit (ttm)N/A
EBITDA -24.93M
Net income avi to common (ttm)-18.49M
Diluted EPS (ttm)-0.0500
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)28.05M
Total cash per share (mrq)0.06
Total debt (mrq)1.38M
Total debt/equity (mrq)2.80%
Current ratio (mrq)3.27
Book value per share (mrq)0.11

Cash flow statement

Operating cash flow (ttm)-19.93M
Levered free cash flow (ttm)-19.04M